100% Insulin Independence: Why Eledon’s Breakthrough is a Pillar, Not a Cure

03/03/2026 admin 2

Eledon Pharmaceuticals recently achieved 100% insulin independence in an early-phase islet transplant trial using its anti-CD40L drug, tegoprubart. It’s a massive step forward in transplant immunology that avoids the toxicity of standard drugs. But why isn’t it a cure yet, and how does it fit into the actual blueprint of a functional cure?

Explore a Decade of Diabetes Insights with Diabettech AI

25/02/2026 admin 3

After 10+ years of documenting the diabetes landscape, Diabettech is launching diabettech.ai—a custom research tool designed to help you navigate a decade’s worth of articles and reports. Powered by an LLM interface, this tool allows you to “interrogate” the site’s data to find specific answers on everything from cures to n=1 observations.
​Key highlights of the beta launch:
​Targeted Accuracy: Built to stick strictly to Diabettech articles and comments to minimize “hallucinations.”
​Research-Focused: Optimized as a precision tool rather than a standard chatbot to provide relevant article links.
​Sustainable Design: Privately funded and optimized for efficiency to manage resource costs and query speeds.
​Ready to dive into the archives? Visit diabettech.ai to start your research and share your feedback on the beta experience.

Snaq. AI helping to manage glucose patterns.
Diabetes and Data. What more can we learn? Part 1.

Diabetes and Data. What more can we learn? Part 1.

25/04/2024 admin 2

Extracting data from smartwatches and other devices presents an opportunity like never beforento observe the relationship between behaviour and diabetes outcomes. This n=1 investigation strives to start the process off and highkight how some behaviours interact with Diabetes management.